These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16550732)

  • 1. Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder.
    Burian M; Neumann T; Weber M; Brandt R; Geisslinger G; Mitrovic V; Hamm C
    Int J Clin Pharmacol Ther; 2006 Mar; 44(3):107-12. PubMed ID: 16550732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nickel release after implantation of the Amplatzer occluder.
    Ries MW; Kampmann C; Rupprecht HJ; Hintereder G; Hafner G; Meyer J
    Am Heart J; 2003 Apr; 145(4):737-41. PubMed ID: 12679773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder.
    Lairakdomrong K; Srimahachota S; Lertsapcharoen P; Chaipromprasit J; Boonyaratavej S; Kaewsukkho P
    J Med Assoc Thai; 2013 Sep; 96(9):1127-34. PubMed ID: 24163987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Two Percutaneous Atrial Septal Defect Occluders for Device Healing and Nickel Release in a Chronic Porcine Model.
    Jalal Z; Boudjemline Y; Iriart X; Seguela PE; Delmond S; Loyer V; Gonthier D; Bernus O; Durand M; Bordenave L; Thambo JB
    J Interv Cardiol; 2020; 2020():8413831. PubMed ID: 32665769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial.
    Wintzer-Wehekind J; Horlick E; Ibrahim R; Cheema AN; Labinaz M; Nadeem N; Osten M; Côté M; Marsal JR; Rivest D; Marrero A; Houde C; Rodés-Cabau J
    JAMA Cardiol; 2021 Feb; 6(2):209-213. PubMed ID: 32965476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-expanding platinum-coated nitinol devices for transcatheter closure of atrial septal defect: prevention of nickel release.
    Lertsapcharoen P; Khongphatthanayothin A; Srimahachota S; Leelanukrom R
    J Invasive Cardiol; 2008 Jun; 20(6):279-83. PubMed ID: 18523320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale/ atrium septum defect closure.
    Polzin A; Dannenberg L; Sophia Popp V; Kelm M; Zeus T
    Platelets; 2016 Jun; 27(4):317-21. PubMed ID: 26556101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.
    Rodés-Cabau J; Horlick E; Ibrahim R; Cheema AN; Labinaz M; Nadeem N; Osten M; Côté M; Marsal JR; Rivest D; Marrero A; Houde C
    JAMA; 2015 Nov; 314(20):2147-54. PubMed ID: 26551304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
    Wilmshurst PT; Nightingale S; Walsh KP; Morrison WL
    Heart; 2005 Sep; 91(9):1173-5. PubMed ID: 16103551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience.
    Chan KC; Godman MJ; Walsh K; Wilson N; Redington A; Gibbs JL
    Heart; 1999 Sep; 82(3):300-6. PubMed ID: 10455079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias.
    Wilson NJ; Smith J; Prommete B; O'Donnell C; Gentles TL; Ruygrok PN
    Heart Lung Circ; 2008 Aug; 17(4):318-24. PubMed ID: 18407789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter closure of atrial septal defect with atrial septal occluder in a patient with nickel allergy.
    Arı H; Arı S; Tütüncü A; Karakuş A; Melek M
    Turk Kardiyol Dern Ars; 2017 Jun; 45(4):355-357. PubMed ID: 28595206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a parylene-coated occluder for atrial septal defect: a prospective, multi-center, randomized controlled clinical trial.
    Yang K; Lyu JH; Hu HB; Wu WH; Zhang GJ; Jin JL; Liu YH; Feng Y; Wang LM; Zhao SH; Jiang SL; Li W; Pan XB
    Chin Med J (Engl); 2021 Nov; 134(22):2685-2691. PubMed ID: 34759229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report.
    Lai DW; Saver JL; Araujo JA; Reidl M; Tobis J
    Catheter Cardiovasc Interv; 2005 Nov; 66(3):424-6. PubMed ID: 16208708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nickel for your thoughts: Survey of the Congenital Cardiovascular Interventional Study Consortium (CCISC) for nickel allergy.
    Gordon BM; Moore JW
    J Invasive Cardiol; 2009 Jul; 21(7):326-9. PubMed ID: 19571342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of Nickel Levels in Patients with Atrial Septal Defect Undergoing Amplatzer Device Closure.
    Narayana G; Ramagopal G; Duggal B; Bansal NO
    Heart Views; 2018; 19(3):85-87. PubMed ID: 31007856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate term follow-up on transcatheter closure of atrial septal defects by Amplatzer septal occluder.
    Durongpisitkul K; Soongswang J; Laohaprasitiporn D; Nana A
    J Med Assoc Thai; 2000 Sep; 83(9):1045-53. PubMed ID: 11075972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects.
    Berger F; Vogel M; Alexi-Meskishvili V; Lange PE
    J Thorac Cardiovasc Surg; 1999 Oct; 118(4):674-8; discussion 678-80. PubMed ID: 10504632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects.
    Rodés-Cabau J; Palacios A; Palacio C; Girona J; Galve E; Evangelista A; Casaldáliga J; Albert D; Picó M; Soler-Soler J
    Int J Cardiol; 2005 Jan; 98(1):107-12. PubMed ID: 15676174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.